ReviewFrontiers in genetics2025
Gene-LLMs: a comprehensive survey of transformer-based genomic language models for regulatory and clinical genomics.
Review in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Eras of bioinformatics technologies from command-line interfaces to artificial intelligence (AI) chatbots.Briefings in bioinformatics · 2026Review
- Liquid Biopsy in Colorectal Cancer: Future Perspectives Through the Lens of Artificial Intelligence-A Comprehensive Review of Novel Literature.International journal of molecular sciences · 2026Review
- Surveillance without silos: a One Health data imperative for avian influenza in West Africa.Frontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The convergence of natural language processing (NLP) and genomics has given rise to a new class of transformer-based models-genome large language models (Gene-LLMs)-capable of interpreting the language of life at an unprecedented scale and resolution. These models represent a revolution in the field of bioinformatics since they use only raw nucleotide sequences, gene expression data, and multi-omic annotations, leveraging self-supervised pretraining to decipher complex regulatory grammars hidden within the genome. This survey presents a comprehensive overview of the Gene-LLM lifecycle, including stages such as raw data ingestion, k-mer or gene-level tokenization, and pretext learning tasks like masked nucleotide prediction and sequence alignment. We specify their wide range of applications, spanning crucial downstream activities such as finding the enhancer or promoter, modeling the chromatin state, predicting the RNA-protein interaction, and creating synthetic sequences. We further explore how Gene-LLMs have created an impact on functional genomics, clinical diagnostics, and evolutionary inference by analyzing recent benchmarks, including CAGI5, GenBench, NT-Bench, and BEACON. We also highlight recent advances encoder-decoder modifications and the incorporation of positional embeddings, a feature specific to living organisms, which may enhance both interpretability and translational potential. Finally, this study outlines a pathway toward federated genomic learning, multimodal sequence modeling, and low-resource adaptation for rare variant discovery, establishing Gene-LLMs as a cornerstone technology for the responsible and proactive future of biomedicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.